These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Toxicity of middle molecules: clinical evaluation using a selective filtration artificial kidney. Jörstad S; Smeby LC; Wideröe TE Artif Organs; 1981; 4 Suppl():98-103. PubMed ID: 7295103 [TBL] [Abstract][Full Text] [Related]
47. [Depurative efficiency of intermediate and large molecules with different hemodialysis modalities]. Maduell F Nefrologia; 2005; 25 Suppl 2():15-8. PubMed ID: 16050396 [TBL] [Abstract][Full Text] [Related]
48. Influence of uremic middle molecules on in vitro stimulated lymphocytes and interleukin-2 production. Severini G; Diana L; Di Giovannandrea R; Sagliaschi G ASAIO J; 1996; 42(1):64-7. PubMed ID: 8808461 [TBL] [Abstract][Full Text] [Related]
50. The influence of larger molecules on cellular response in uremia. Giacchino F; Quarello F; Pozzato M; Giraudo G; Formica M; Quattrocchio G; Piccoli G Trans Am Soc Artif Intern Organs; 1983; 29():29-32. PubMed ID: 6608816 [No Abstract] [Full Text] [Related]
51. What we have learned about uremia from peritoneal dialysis. Nolph KD ASAIO J; 1992; 38(4):745-50. PubMed ID: 1450467 [TBL] [Abstract][Full Text] [Related]
52. Prescribing peritoneal dialysis in each patient with uremic toxins as the treatment marker. Yokoayama K; Mitome J; Matsuo N; Tanno Y; Ohkido I; Hayakawa H; Hanaoka K; Yamamoto H; Hosoya T Nephrol Dial Transplant; 2009 Dec; 24(12):3900-1. PubMed ID: 19762606 [No Abstract] [Full Text] [Related]
53. Hemofiltration-induced serum modifications in the pattern of larger molecules. David S; Barani R; Buzio C; Arisi L; Quaretti P Adv Exp Med Biol; 1987; 223():281-6. PubMed ID: 3447447 [No Abstract] [Full Text] [Related]
54. A bench to bedside view of uremic toxins. Vanholder R; Baurmeister U; Brunet P; Cohen G; Glorieux G; Jankowski J; J Am Soc Nephrol; 2008 May; 19(5):863-70. PubMed ID: 18287557 [TBL] [Abstract][Full Text] [Related]
55. Mathematical formulation of the dialysis index for middle molecules, D1(MM). Milutinovic J; Babb AL; Eschbach JW; Follette WC; Graefe U; Strand MJ; Scribner BH Artif Organs; 1978 Feb; 2(1):51-4. PubMed ID: 687021 [No Abstract] [Full Text] [Related]
57. Middle molecules in hepatic coma and uremia. Chang TM; Lister C Artif Organs; 1981; 4 Suppl():169-72. PubMed ID: 7295086 [No Abstract] [Full Text] [Related]
58. [The anticoagulant activity of the plasma ultrafiltrate as a possible criterion of uremic poisoning]. Sukhanov VA; Chuzhinov SV; Koriakov IO; Zlokazov VB Ter Arkh; 1991; 63(6):68-71. PubMed ID: 1948752 [No Abstract] [Full Text] [Related]
59. [Electrophysiological study of the neurotoxicity of middle molecules]. Bernard PJ; Rinaudo JB; Crevat A; Gallice P; Fournier N; Murisasco A; Saingra S; Frayssinet R; Henry JF J Urol Nephrol (Paris); 1979 Dec; 85(12):883-7. PubMed ID: 554876 [No Abstract] [Full Text] [Related]
60. Parathyroid hormone as a uremic toxin: its influence on T lymphocyte receptors. Giacchino F; Quattrocchio G; Piccoli G Clin Nephrol; 1985 Feb; 23(2):105-6. PubMed ID: 3872757 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]